期刊文献+

760例高血糖患者血脂分析 被引量:3

下载PDF
导出
摘要 目的:糖尿病患者存在多种血脂异常,处理各种血脂异常原则不尽相同,对糖尿病患者进行血脂四项测定并分类,探讨糖尿病的血脂异常类型。方法:76 0例血糖>7.0mmol/L的标本进行血脂测定,其中男性374例,平均年龄5 2岁,女性386例,平均年龄5 5岁,并进行分类讨论。结果:糖尿病患者存在多种血脂异常,其中以甘油三酯(TG)升高的人数最多348例,占总人数4 5 .8% ,其次是低密度脂蛋白(LDL)升高人数30 3例占总人数39.9% ,胆固醇(TC)升高2 4 0例,占总人数31.6 % ,高密度脂蛋白(HDL)降低171例占总人数2 2 .5 %。结论:糖尿病患者血脂异常以TG和LDL为主。从本文76 0例高血糖患者血脂分析看出LDL升高是一个不能忽视的问题,并且TC升高HDL降低也有一定比例。TC、LDL、HDL各项都是心血管病的独立致病因素,是不能忽视的指标。糖尿病人应定期进行血脂测定,针对不同血脂异常类型或者各个独立指标进行不同调脂治疗,对糖尿病人的治疗和预后有很大帮助。
作者 张传洽
出处 《实用医技杂志》 2005年第04B期1000-1001,共2页 Journal of Practical Medical Techniques
  • 相关文献

参考文献3

二级参考文献34

  • 1Pyorala K, Pedersen TR, Kjelshus J, et al. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease .A subgroup analysis of the scandinavian simvastatin survival study. Diabetes Care, 1997; 20:614~ 620
  • 2Sacks FM, Pfetter MA , Moye LA ,et al. Cholesterol and recurrent events trial investigators. The effect of pravastatin ion coronary events after myocardial infarction in patients with average cholesterol levels . New Engl J Med, 1996; 335:1001 ~ 1009
  • 3Dilys J. Freeman, John Norrie, Naveed Sattur, et al.Pravastatin and the development of diabetes mellitus evidence for a protective treatment effect in the use of Scotland coronary prevention study. Circulation, 2001; 103:357 ~ 362
  • 4Koskinen P , Manttari M, Manninen V, et al. Coronary heart disease incidence in NIDDM patients in the Helsinski Heart Study. Diabetes Care,1992; 15:820~825
  • 5Steven A. Grover, Louis Coupal, Hanna Zowall, et al. Cost effectiveness of treating hyperlipidemmia in the presence of diabtes. Circulation, 2000; 102:722~ 727
  • 6American Diabetes Associtation. Management of dyslipidemia in adults with diabetes. Diabetes Care, 2000; 23 (Suppl 1 ): S57 ~ S60
  • 7Schoonjans K, Staels B, Auerx J. Role of the Peroxisome proliferatoractivator receptor (PPAR) in medating the effects of fibrates and fatty acids on gene expression. J Lipid Res, 1996;37:907 ~ 925
  • 8Fagan TC, Sowers J. Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy(Editorial] . Arc Intern Med, 1999; 159:1033~ 1034
  • 9Wagenknecht LE, D'A agostino RB Jr, Haffner SM, et al. Impaired glucose tolerance, type 2diabetes. and carotid wall thickness: the Insulin Resistance Atherosclerosis Study. Diabetes Care, 1998;21:1812 ~ 1818
  • 10Lakso M, Lehto S, Penttila I, et al. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non - insulindependent diabetes. Circulation, 1993; 88:14421 ~ 1430

共引文献5

同被引文献22

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部